Ion Platform Poised for Cost Optimization: A Margin Lever for ISRG?

Key Takeaways ISRG's Ion procedures rose 52% in Q2 2025, with global installs reaching 905 systems.ISRG's gross margin slipped to 67.9% on Ion mix, da Vinci 5 sales, and tariff headwinds.ISRG is prioritizing Ion cost efficiency to offset tariffs and protect profitability.Intuitive Surgical’s (ISRG) Ion platform is rapidly scaling, with procedures surging 52% year over year to 35,000 in second-quarter 2025. Yet management’s commentary made clear that Ion’s next growth phase hinges not only on utilization gai ...